Schedule 13G ownership disclosure
EIGER BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 28249U105
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 12.3500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-23-005363
- Form type
- SC 13G
- Filer
- AMERIPRISE FINANCIAL INC
- CIK
- CIK 820027
- Filed
- Jan 10, 2023
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership